questionsmedicales.fr
Environnement et santé publique
Santé publique
Facteurs épidémiologiques
Facteurs épidémiologiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Polymorphism, Single Nucleotide
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteurs épidémiologiques : Questions médicales les plus fréquentes",
"headline": "Facteurs épidémiologiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteurs épidémiologiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-10",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteurs épidémiologiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Santé publique",
"url": "https://questionsmedicales.fr/mesh/D011634",
"about": {
"@type": "MedicalCondition",
"name": "Santé publique",
"code": {
"@type": "MedicalCode",
"code": "D011634",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteurs âges",
"alternateName": "Age Factors",
"url": "https://questionsmedicales.fr/mesh/D000367",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs âges",
"code": {
"@type": "MedicalCode",
"code": "D000367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Âge de début",
"alternateName": "Age of Onset",
"url": "https://questionsmedicales.fr/mesh/D017668",
"about": {
"@type": "MedicalCondition",
"name": "Âge de début",
"code": {
"@type": "MedicalCode",
"code": "D017668",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.250.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Âge maternel",
"alternateName": "Maternal Age",
"url": "https://questionsmedicales.fr/mesh/D008423",
"about": {
"@type": "MedicalCondition",
"name": "Âge maternel",
"code": {
"@type": "MedicalCode",
"code": "D008423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.250.550"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Biais (épidémiologie)",
"alternateName": "Bias",
"url": "https://questionsmedicales.fr/mesh/D015982",
"about": {
"@type": "MedicalCondition",
"name": "Biais (épidémiologie)",
"code": {
"@type": "MedicalCode",
"code": "D015982",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Biais de l'observateur",
"alternateName": "Observer Variation",
"url": "https://questionsmedicales.fr/mesh/D015588",
"about": {
"@type": "MedicalCondition",
"name": "Biais de l'observateur",
"code": {
"@type": "MedicalCode",
"code": "D015588",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.500.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Biais de sélection",
"alternateName": "Selection Bias",
"url": "https://questionsmedicales.fr/mesh/D015983",
"about": {
"@type": "MedicalCondition",
"name": "Biais de sélection",
"code": {
"@type": "MedicalCode",
"code": "D015983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Causalité",
"alternateName": "Causality",
"url": "https://questionsmedicales.fr/mesh/D015984",
"about": {
"@type": "MedicalCondition",
"name": "Causalité",
"code": {
"@type": "MedicalCode",
"code": "D015984",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.625"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteurs précipitants",
"alternateName": "Precipitating Factors",
"url": "https://questionsmedicales.fr/mesh/D015985",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs précipitants",
"code": {
"@type": "MedicalCode",
"code": "D015985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.625.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Comorbidité",
"alternateName": "Comorbidity",
"url": "https://questionsmedicales.fr/mesh/D015897",
"about": {
"@type": "MedicalCondition",
"name": "Comorbidité",
"code": {
"@type": "MedicalCode",
"code": "D015897",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.687"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Multimorbidité",
"alternateName": "Multimorbidity",
"url": "https://questionsmedicales.fr/mesh/D000076322",
"about": {
"@type": "MedicalCondition",
"name": "Multimorbidité",
"code": {
"@type": "MedicalCode",
"code": "D000076322",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.687.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de confusion (épidémiologie)",
"alternateName": "Confounding Factors, Epidemiologic",
"url": "https://questionsmedicales.fr/mesh/D015986",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de confusion (épidémiologie)",
"code": {
"@type": "MedicalCode",
"code": "D015986",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.718"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Modificateur d'effet épidémiologique",
"alternateName": "Effect Modifier, Epidemiologic",
"url": "https://questionsmedicales.fr/mesh/D015987",
"about": {
"@type": "MedicalCondition",
"name": "Modificateur d'effet épidémiologique",
"code": {
"@type": "MedicalCode",
"code": "D015987",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Effet de cohorte",
"alternateName": "Cohort Effect",
"url": "https://questionsmedicales.fr/mesh/D015988",
"about": {
"@type": "MedicalCondition",
"name": "Effet de cohorte",
"code": {
"@type": "MedicalCode",
"code": "D015988",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Effet du travailleur en bonne santé",
"alternateName": "Healthy Worker Effect",
"url": "https://questionsmedicales.fr/mesh/D015989",
"about": {
"@type": "MedicalCondition",
"name": "Effet du travailleur en bonne santé",
"code": {
"@type": "MedicalCode",
"code": "D015989",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Effet placebo",
"alternateName": "Placebo Effect",
"url": "https://questionsmedicales.fr/mesh/D015990",
"about": {
"@type": "MedicalCondition",
"name": "Effet placebo",
"code": {
"@type": "MedicalCode",
"code": "D015990",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.875"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Effet nocebo",
"alternateName": "Nocebo Effect",
"url": "https://questionsmedicales.fr/mesh/D064786",
"about": {
"@type": "MedicalCondition",
"name": "Effet nocebo",
"code": {
"@type": "MedicalCode",
"code": "D064786",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.875.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Effet nocebo",
"alternateName": "Nocebo Effect",
"url": "https://questionsmedicales.fr/mesh/D064786",
"about": {
"@type": "MedicalCondition",
"name": "Effet nocebo",
"code": {
"@type": "MedicalCode",
"code": "D064786",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.875.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antécédents gynécologiques et obstétricaux",
"alternateName": "Reproductive History",
"url": "https://questionsmedicales.fr/mesh/D017584",
"about": {
"@type": "MedicalCondition",
"name": "Antécédents gynécologiques et obstétricaux",
"code": {
"@type": "MedicalCode",
"code": "D017584",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.812"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gravidité",
"alternateName": "Gravidity",
"url": "https://questionsmedicales.fr/mesh/D020073",
"about": {
"@type": "MedicalCondition",
"name": "Gravidité",
"code": {
"@type": "MedicalCode",
"code": "D020073",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.812.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Parité",
"alternateName": "Parity",
"url": "https://questionsmedicales.fr/mesh/D010298",
"about": {
"@type": "MedicalCondition",
"name": "Parité",
"code": {
"@type": "MedicalCode",
"code": "D010298",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.812.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Intervalle sériel de l'infection",
"alternateName": "Serial Infection Interval",
"url": "https://questionsmedicales.fr/mesh/D000088822",
"about": {
"@type": "MedicalCondition",
"name": "Intervalle sériel de l'infection",
"code": {
"@type": "MedicalCode",
"code": "D000088822",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.844"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteurs sexuels",
"alternateName": "Sex Factors",
"url": "https://questionsmedicales.fr/mesh/D012737",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs sexuels",
"code": {
"@type": "MedicalCode",
"code": "D012737",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndémique",
"alternateName": "Syndemic",
"url": "https://questionsmedicales.fr/mesh/D000076603",
"about": {
"@type": "MedicalCondition",
"name": "Syndémique",
"code": {
"@type": "MedicalCode",
"code": "D000076603",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.937"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Facteurs épidémiologiques",
"alternateName": "Epidemiologic Factors",
"code": {
"@type": "MedicalCode",
"code": "D015981",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J X Chen",
"url": "https://questionsmedicales.fr/author/J%20X%20Chen",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China."
}
},
{
"@type": "Person",
"name": "L G Tian",
"url": "https://questionsmedicales.fr/author/L%20G%20Tian",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China."
}
},
{
"@type": "Person",
"name": "Rong Zhang",
"url": "https://questionsmedicales.fr/author/Rong%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China."
}
},
{
"@type": "Person",
"name": "Yanyan Hu",
"url": "https://questionsmedicales.fr/author/Yanyan%20Hu",
"affiliation": {
"@type": "Organization",
"name": "1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China."
}
},
{
"@type": "Person",
"name": "Hongwei Zhou",
"url": "https://questionsmedicales.fr/author/Hongwei%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Novel single nucleotide polymorphisms in gestational diabetes mellitus.",
"datePublished": "2022-11-12",
"url": "https://questionsmedicales.fr/article/36375523",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cca.2022.11.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36847373",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3791/64361"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between single nucleotide polymorphisms in exon 3 of the",
"datePublished": "2022-11-15",
"url": "https://questionsmedicales.fr/article/36380611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13816810.2022.2092757"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.",
"datePublished": "2022-09-05",
"url": "https://questionsmedicales.fr/article/36065506",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/17512433.2022.2118714"
}
},
{
"@type": "ScholarlyArticle",
"name": "Potential role of FKBP5 single-nucleotide polymorphisms in functional seizures.",
"datePublished": "2023-03-21",
"url": "https://questionsmedicales.fr/article/36825897",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/epi4.12716"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D015981"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteurs épidémiologiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteurs épidémiologiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteurs épidémiologiques",
"description": "Comment évaluer les facteurs épidémiologiques d'une maladie ?\nQuels outils sont utilisés pour le diagnostic épidémiologique ?\nQuelle est l'importance des études de cohorte ?\nComment les facteurs environnementaux sont-ils diagnostiqués ?\nQuel rôle joue la surveillance épidémiologique ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteurs épidémiologiques",
"description": "Quels symptômes peuvent indiquer une épidémie ?\nComment les symptômes varient-ils selon les populations ?\nQuels symptômes sont liés aux maladies infectieuses ?\nLes symptômes peuvent-ils être influencés par des facteurs socio-économiques ?\nComment les symptômes psychologiques sont-ils pris en compte ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteurs épidémiologiques",
"description": "Quelles stratégies de prévention sont efficaces ?\nComment les facteurs épidémiologiques influencent-ils la prévention ?\nQuel rôle joue la sensibilisation dans la prévention ?\nComment les politiques de santé publique influencent-elles la prévention ?\nLes programmes de dépistage sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteurs épidémiologiques",
"description": "Quels traitements sont influencés par des facteurs épidémiologiques ?\nComment les traitements sont-ils adaptés aux épidémies ?\nQuel est l'impact des traitements préventifs ?\nComment évaluer l'efficacité des traitements ?\nLes traitements varient-ils selon les régions géographiques ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteurs épidémiologiques",
"description": "Quelles complications peuvent survenir lors d'épidémies ?\nComment les complications affectent-elles la santé publique ?\nLes complications varient-elles selon les groupes d'âge ?\nQuel est l'impact des complications sur la qualité de vie ?\nComment prévenir les complications liées aux maladies ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteurs épidémiologiques",
"description": "Quels sont les principaux facteurs de risque épidémiologiques ?\nComment les facteurs environnementaux influencent-ils les risques ?\nLes antécédents familiaux sont-ils des facteurs de risque ?\nQuel rôle joue le mode de vie dans les facteurs de risque ?\nComment les facteurs de risque sont-ils identifiés ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer les facteurs épidémiologiques d'une maladie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des études épidémiologiques et des analyses statistiques."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic épidémiologique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enquêtes, les registres de santé et les bases de données sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance des études de cohorte ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'observer l'incidence des maladies sur des groupes spécifiques dans le temps."
}
},
{
"@type": "Question",
"name": "Comment les facteurs environnementaux sont-ils diagnostiqués ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études de cas-témoins et des analyses de l'exposition environnementale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la surveillance épidémiologique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de détecter et de suivre les tendances des maladies dans la population."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une épidémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une augmentation soudaine de cas similaires dans une population peut être un indicateur."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les populations ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en fonction de la génétique, de l'environnement et des comportements."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux maladies infectieuses ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux et douleurs musculaires sont souvent associés aux infections."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être influencés par des facteurs socio-économiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conditions socio-économiques peuvent affecter l'accès aux soins et la santé globale."
}
},
{
"@type": "Question",
"name": "Comment les symptômes psychologiques sont-ils pris en compte ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent évalués dans le cadre d'études sur la santé mentale et le bien-être."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont efficaces ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de vaccination et l'éducation à la santé sont des stratégies clés."
}
},
{
"@type": "Question",
"name": "Comment les facteurs épidémiologiques influencent-ils la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à identifier les populations à risque et à cibler les interventions préventives."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la sensibilisation dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sensibilisation augmente la connaissance des risques et encourage des comportements sains."
}
},
{
"@type": "Question",
"name": "Comment les politiques de santé publique influencent-elles la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles établissent des directives et des ressources pour réduire les risques de maladies."
}
},
{
"@type": "Question",
"name": "Les programmes de dépistage sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de détecter précocement les maladies et d'améliorer les résultats de santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont influencés par des facteurs épidémiologiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent varier selon la prévalence des maladies dans une population donnée."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils adaptés aux épidémies ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont ajustés en fonction des caractéristiques de la maladie et des populations touchées."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des traitements préventifs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements préventifs réduisent l'incidence des maladies dans les populations à risque."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des essais cliniques et des études de suivi sur les résultats de santé."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon les régions géographiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des ressources et des besoins locaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir lors d'épidémies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la surcharge des systèmes de santé et l'augmentation de la mortalité."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la santé publique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des coûts élevés et des défis pour la gestion des soins de santé."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon les groupes d'âge ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes et les personnes âgées peuvent avoir des complications différentes."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des complications sur la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie et augmenter le besoin de soins."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux maladies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des interventions précoces et un suivi régulier des patients à risque."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque épidémiologiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe, le statut socio-économique et les comportements de santé."
}
},
{
"@type": "Question",
"name": "Comment les facteurs environnementaux influencent-ils les risques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution, le climat et l'accès aux soins peuvent augmenter les risques de maladies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils des facteurs de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents familiaux peuvent prédisposer à certaines maladies génétiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le mode de vie dans les facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent le risque de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque sont-ils identifiés ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études épidémiologiques et des analyses de données de santé publique."
}
}
]
}
]
}
The association between gestational diabetes mellitus (GDM) and single nucleotide polymorphisms (SNPs) has attracted global research attention. Exploring SNPs can help us further understand the pathog...
Mutations in the mitochondrial genome (mtDNA) have been associated with maternally inherited genetic diseases. However, interest in mtDNA polymorphisms has increased in recent years due to the recentl...
The mutations in the αA-crystallin (CRYAA) gene may contribute to the development of age-related cataract (ARC). In this study, we searched for single nucleotide polymorphisms (SNP) in exons of CRYAA ...
Peripheral venous blood was collected for the extraction of genomic DNA. Three exons of CRYAA were sequenced to detect SNPs. The frequency distributions of alleles and genotypes were compared between ...
There were 618 patients with various subtypes of ARC (nuclear cataract [NC], cortical cataract [CC], posterior subcapsular cataract [PSC]). The control group comprised 236 patients. The incidence of e...
The SNP rs76740365 G>A in exon 3 of the CRYAA gene is associated with greater susceptibility of ARC, particularly the PSC subtype. Individuals carrying the SNP rs76740365 G>A may be more likely to dev...
Metformin has been recognized as the first-choice drug for type 2 diabetes mellitus (T2DM). The potency of metformin in the treatment of type 2 diabetes has always been in the spotlight and shown sign...
Here, we reviewed the current knowledge about gene polymorphisms impacting metformin efficacy based on transporter and drug target proteins....
The reason for the difference in clinical drug potency of metformin can be attributed to the gene polymorphism of drug transporters and drug target proteins in the human body. Substantial evidence sho...
We investigated the associations between FKBP5 single-nucleotide polymorphisms (SNPs) and functional seizures (FS)....
Seventy patients with FS, 140 with major depressive disorder (MDD), and 140 healthy controls were studied. Their DNAs were analyzed for the rs1360780 in the 3' region and rs9470080 in the 5' region of...
Patients with FS and those with MDD had less GG and more AA genotypes in both rs9470080 and rs1360780 SNPs compared with those in healthy controls. Similar results were observed for allelic frequencie...
Patients with FS and those with MDD had significantly different genotypes in both rs9470080 and rs1360780 SNPs compared with those in healthy controls. However, it seems that FKBP5 polymorphisms were ...
The susceptibility of different individuals to anesthetics varies widely, and sevoflurane is no exception. We hypothesized that polymorphisms in genes involved in pharmacokinetics and pharmacodynamics...
Genome-wide copy number profiling by single-nucleotide polymorphism (SNP) array is increasingly employed in the clinical diagnostic workup of melanocytic tumors. We present our SNP array results on 67...
Systematic research on the associations between vital single nucleotide polymorphisms (SNPs) in MALAT1 and cancer risk was still lacking. Thus, we performed this study....
The literature searches were until April 1, 2022. The pooled association-analysis results were assessed by odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) in three genetic model...
Eighteen articles about four SNPs (rs619586, rs664589, rs1194338, and rs3200401) involving 11,843 cancer cases and 14,682 controls were collected. Rs619586, rs664589, and rs1194338 were associated wit...
The functional SNPs in MALAT1 correlated with cancer risk. MALAT1 and its vital functional SNPs might be potential biomarkers for predicting the risk and prognosis of two types of cancer, especially C...
Single-nucleotide polymorphisms in G protein subunits are linked to an increased risk of cardiovascular events among the general population. We assessed the effects of...
Gender incongruence (GI) is characterized by a marked incongruence between an individual's experienced/expressed gender and the assigned sex at birth. It includes strong displeasure about his or her s...
We analyzed 74 single nucleotide polymorphisms located at the metabotropic glutamate receptors (mGluR1, mGluR3, mGluR4, mGluR5, mGluR7 and mGluR8) in 94 transgender...
After analysis of allele and genotypic frequencies, we found twenty-five polymorphisms with significant differences at level P ≤ 0.05, five at P ≤ 0.005 and two at P ≤ 0.0005. Furthermore, the only tw...
We provide genetic evidence that the mGluR7, and therefore glutamatergic neurotransmission, may be involved in GI and GD....